Publications: Prof. Dr. med. J. Distler
- Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based study. Rheumatol Int. 2023;43(3): 495-502
- Assessment of myocardial fibrosis in patients with systemic sclerosis using [68Ga]Ga-FAPI-04-PET-CT. Eur J Nucl Med Mol Imaging. 2023;50(6): 1629-1635
- Response to: 'Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'' by Jeny et al. Ann Rheum Dis. 2022;81(12):
- Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects. Respir Res. 2022;23(1):
- A broad look into the future of systemic sclerosis. Ther Adv Musculoskelet Dis. 2022;14():
- The role of antifibrotics in the treatment of rheumatoid arthritis-associated interstitial lung disease. Ther Adv Musculoskelet Dis. 2022;14():
- Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology (Oxford). 2022;61(3): 1141-1147
- Biophysical phenotyping of circulating immune cells identifies a distinct monocyte-driven signature in systemic sclerosis. Arthritis Rheumatol. 2022;():
- Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153. Bone Res. 2022;10(1):
- LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis. Clin Transl Med. 2022;12(1):
- Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial. Arthritis Rheumatol. 2022;74(6): 1039-1047
- Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry. Arthritis Res Ther. 2022;24(1):
- Epigenetic profiling of twins identify repression of KLF4 as a novel pathomechanism in systemic sclerosis. Ann Rheum Dis. 2022;81(2): 151-152
- Genetic Associations of Non-Major Histocompatibility Complex Susceptibility Loci with Systemic Sclerosis in a Han Chinese Population. J Invest Dermatol. 2022;142(7): 2039-2042.e7
- Patient's Perception of Digital Symptom Assessment Technologies in Rheumatology: Results From a Multicentre Study. Front Public Health. 2022;10():
- Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force. Transplant Cell Ther. 2022;28(8): 426-445
- Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis. Arthritis Res Ther. 2022;24(1):
- Nintedanib reduces alloimmune-induced chronic airway changes in murine tracheal allografts. Transpl Immunol. 2022;73():
- Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. Clin Exp Rheumatol. 2022;40(2): 274-283
- Purinergic signalling in systemic sclerosis. Rheumatology (Oxford). 2022;61(7): 2770-2782
- Impaired Mitochondrial Transcription Factor A Expression Promotes Mitochondrial Damage to Drive Fibroblast Activation and Fibrosis in Systemic Sclerosis. Arthritis Rheumatol. 2022;74(5): 871-881
- Platelet Phagocytosis via P-selectin Glycoprotein Ligand 1 and Accumulation of Microparticles in Systemic Sclerosis. Arthritis Rheumatol. 2022;74(2): 318-328
- Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. NPJ Genom Med. 2022;7(1):
- Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score. Arthritis Rheumatol. 2022;74(3): 518-526
- Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open. 2022;8(2):
- Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment. Rheumatology (Oxford). 2022;61(10): 4035-4046
- Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling. Front Cardiovasc Med. 2022;9():
- CIRCULATING MONOCYTES HAVE DISTINCT PHYSICAL PROPERTIES THAT CORRELATE WITH DISEASE ACTIVITY AND SEVERITY AND PREDICT PROGRESSION IN SYSTEMIC SCLEROSIS Ann Rheum Dis. 2021;80 Suppl 1(): 1238-1238
- Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study. Sci Rep. 2021;11(1):
- S100A4 PLASMA LEVELS CORRELATE WITH DISEASE ACTIVITY, SKIN FIBROSIS AND INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS PATIENTS Ann Rheum Dis. 2021;80 Suppl 1(): 1233-1233
- INACTIVATION OF ALDEHYDE DEHYDROGENASE 3A2 INHIBITS FIBROBLAST ACTIVATION AND TISSUE FIBROSIS Ann Rheum Dis. 2021;80 Suppl 1(): 391-391
- X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc). Ann Rheum Dis. 2021;80(8): 1048-1056
- INHIBITION OF AUTOPHAGY PREVENTS PROGRESSION OF FIBROSIS IN MURINE MODELS OF SYSTEMIC SCLEROSIS Ann Rheum Dis. 2021;80 Suppl 1(): 1075-1075
- Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial. Lancet Respir Med. 2021;9(1): 96-106
- Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma. Ann Rheum Dis. 2021;80(7): 920-929
- Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease. Blood. 2021;137(17): 2403-2416
- DYNAMIC CHANGES IN O-GLCNACYLATION REGULATE OSTEOCLAST DIFFERENTIATION AND BONE LOSS IN ARTHRITIS Ann Rheum Dis. 2021;80 Suppl 1(): 121-122
- Response to: 'In search for the ideal anatomical composition of vascularised human skin equivalents for systemic sclerosis translational research: should we recruit the telocytes?' by Manetti and Matucci-Cerinic. Ann Rheum Dis. 2021;80(9):
- The effect of nintedanib versus mycophenolate mofetil in the Fra2 mouse model of systemic sclerosis-associated interstitial lung disease. Clin Exp Rheumatol. 2021;39 Suppl 131(4): 134-141
- ENGRAILED 1 COORDINATES CYTOSKELETAL ORGANIZATION TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND FIBROTIC TISSUE REMODELING Ann Rheum Dis. 2021;80 Suppl 1(): 391-391
- Cytokine-mediated induction of human xylosyltransferase-I in systemic sclerosis skin fibroblasts. Biochem Biophys Res Commun. 2021;549(): 34-39
- Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial. Arthritis Res Ther. 2021;23(1):
- DECLINE IN FORCED VITAL CAPACITY (FVC) IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN THE SENSCIS TRIAL VERSUS HYPOTHETICAL REFERENCE SUBJECTS WITHOUT LUNG DISEASE Ann Rheum Dis. 2021;80 Suppl 1(): 671-672
- EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT Ann Rheum Dis. 2021;80 Suppl 1(): 685-686
- Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation. J Exp Med. 2021;218(9):
- An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod. Arthritis Res Ther. 2021;23(1):
- Untitled Reply Arthritis Rheumatol. 2021;73(1): 179-180
- EFFECTS OF THE AUTOTAXIN INHIBITOR ZIRITAXESTAT ON SKIN AND LUNG FIBROSIS IN A MURINE GRAFT-VERSUS-HOST DISEASE MODEL OF SYSTEMIC SCLEROSIS Ann Rheum Dis. 2021;80 Suppl 1(): 148-149
- Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn's disease patient upon infliximab-induced lupus-like syndrome. Therap Adv Gastroenterol. 2021;14():
- Mouse Models of Skin Fibrosis. Methods Mol Biol. 2021;2299(): 371-383
- Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes. Ann Rheum Dis. 2021;80(8): 1040-1047
- Cellular and molecular mechanisms in fibrosis. Exp Dermatol. 2021;30(1): 121-131
- PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING Ann Rheum Dis. 2021;80 Suppl 1(): 681-682
- TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy. Nat Commun. 2021;12(1):
- Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis. Ann Rheum Dis. 2021;80(6):
- ANTI-S100A4 MONOCLONAL ANTIBODY TREATMENT AMELIORATES SKIN FIBROSIS IN INFLAMMATORY AND NON-INFLAMMATORY PRE-CLINICAL MODELS OF SYSTEMIC SCLEROSIS Ann Rheum Dis. 2021;80 Suppl 1(): 150-150
- Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics. Sci Rep. 2021;11(1):
- 68GA-FAPI-04 PET/CT STUDY EXTENSION FOR THE ASSESSMENT OF FIBROBLAST ACTIVATION AND RISK EVALUATION IN SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE Ann Rheum Dis. 2021;80 Suppl 1(): 165-166
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy. 2021;17(1): 1-382
- Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study Lancet Rheumatol.. 2021;3(3): E175-E184
- The effect of nintedanib versus mycophenolate mofetil in the Fra2 mouse model of systemic sclerosis-associated interstitial lung disease Clin Exp Rheumatol. 2021;39 Suppl 131(4): S134-S141
- Quantification of Ga-68-FAPI-04 in systemic sclerosis-associated interstitial lung disease Reply Lancet Rheumatol.. 2021;3(7): E475-E477
- Author Correction: Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis. Nat Commun. 2021;12(1):
- Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines. 2021;9(6):
- Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic Sclerosis. Front Cell Dev Biol. 2021;9():
- The α7 Nicotinic Acetylcholine Receptor: A Promising Target for the Treatment of Fibrotic Skin Disorders. J Invest Dermatol. 2020;140(12): 2371-2379
- Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al. Ann Rheum Dis. 2020;79(7):
- cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis. Rheumatology (Oxford). 2020;59(12): 3939-3951
- [Autologous hematopoietic stem cell transplantation for systemic sclerosis : Position statement of the stem cell therapy working party of the German Society of Rheumatology]. Z Rheumatol. 2020;79(5): 429-436
- ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis. Arthritis Res Ther. 2020;22(1):
- Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosis. J Clin Invest. 2020;130(9): 4888-4905
- Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication. J Rheumatol. 2020;47(2): 241-248
- Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study. Rheumatology (Oxford). 2020;59(7): 1684-1694
- A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn's disease. Sci Rep. 2020;10(1):
- The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements Lancet Rheumatol.. 2020;2(2): E71-E83
- Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis Arthritis Rheumatol. 2020;72(1): 137-149
- The AP1 Transcription Factor Fosl2 Promotes Systemic Autoimmunity and Inflammation by Repressing Treg Development. Cell Rep. 2020;31(13):
- Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse. Br J Pharmacol. 2020;177(18): 4296-4309
- Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. 2020;55(5):
- Reduced Decline in Forced Vital Capacity in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs) Treated with Nintedanib Arthritis Rheumatol. 2020;72 Suppl 10():
- Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function Eur Respir J. 2020;56 Suppl 64():
- Hsp90 Inhibition Effectively Prevents Progression of Dermal Fibrosis and Induces Regression of Established Bleomycin-Induced Dermal Fibrosis Arthritis Rheumatol. 2020;72 Suppl 10():
- Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets. Rheumatology (Oxford). 2020;59(11): 3380-3389
- TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis. J Clin Invest. 2020;130(5): 2347-2363
- PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis. Ann Rheum Dis. 2020;79(9): 1227-1233
- Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Ann Rheum Dis. 2020;79(11): 1485-1491
- Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic Sclerosis. Arthritis Rheumatol. 2020;72(8): 1385-1395
- Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis. Sci Transl Med. 2020;12(563):
- Acyltransferase skinny hedgehog regulates TGF beta-dependent fibroblast activation in SSc Ann Rheum Dis. 2019;78(9): 1269-1273
- Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis J Control Release. 2019;310(): 198-208
- Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs Ann Rheum Dis. 2019;78(12): 1686-1692
- GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways Nat Commun. 2019;10():
- Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network Am J Respir Crit Care Med. 2019;199():
- Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis Arthritis Rheumatol. 2019;71(12): 2068-2080
- Does anti-acid treatment influence disease progression in SSc-ILD ? data from the German SSc-network Eur Respir J. 2019;54():
- Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network Eur Respir J. 2019;54():
- Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual Ann Rheum Dis. 2019;78(12): 1681-1685
- Shared and distinct mechanisms of fibrosis Nat Rev Rheumatol. 2019;15(12): 705-730
- Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases Eur Respir J. 2019;54(3):
- PU.1 controls fibroblast polarization and tissue fibrosis. Nature. 2019;566(7744): 344-349